Concerta ER 36 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KQ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,601
Award facts
- Contract value 100% obligated
- $11,601.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $11,601.13, with a completion date of January 13, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The parent company, Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract with the Defense Logistics Agency through December 31, 2031, and maintains additional contracts with the Department of Veterans Affairs and other federal agencies. The competitively awarded delivery order demonstrates the contractor's established capability to fulfill federal medical procurement requirements for essential pharmaceutical commodities supporting military treatment facilities and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9KQ5?
SPE2DR26F9KQ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KQ5 worth?
The government has obligated $11,601 on SPE2DR26F9KQ5.
Is contract SPE2DR26F9KQ5 an order under another contract?
Yes. SPE2DR26F9KQ5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KQ5 competed?
The extent of competition for SPE2DR26F9KQ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award